Ron Mayron - BioLight Life Independent Director
| BOLT Stock | ILS 350.00 10.00 2.78% |
Director
Mr. Ron Mayron was appointed Independent Director at Bio Light Israeli Life Sciences Investments Ltd effective July 14, 2015. His work experience includes the following roles Director at Wize Pharma Ltd, Chairman of the Board at Wize Pharma Ltd. from March 31, 2015, Chief Executive Officer at TevaPharmaceutical Industries Ltd. Israel, and Vice President at TevaPharmaceutical Industries Ltd.Israel and Africa between 2009 and 2013. He holds a Bachelors degree in Industrial Engineering and Management Sciences from Ben Gurion University and a MBA degree from Tel Aviv University. since 2015.
| Age | 54 |
| Tenure | 9 years |
| Professional Marks | MBA |
| Phone | 972 7 327 53400 |
| Web | https://bio-light.co.il |
BioLight Life Management Efficiency
The company has return on total asset (ROA) of (0.0925) % which means that it has lost $0.0925 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0911) %, meaning that it generated substantial loss on money invested by shareholders. BioLight Life's management efficiency ratios could be used to measure how well BioLight Life manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Edith Lusky | Bezeq Israeli Telecommunication | 66 | |
| Dov Kotler | Bezeq Israeli Telecommunication | 60 | |
| Orna Peled | Bezeq Israeli Telecommunication | 45 | |
| Ytzhak Edelman | Bezeq Israeli Telecommunication | 64 | |
| Gilead Halevy | Compugen | 51 | |
| Eran Perry | Compugen | N/A | |
| Haggai Herman | Bezeq Israeli Telecommunication | 51 | |
| Dov Hershberg | Compugen | 74 | |
| Amnon Dick | Bezeq Israeli Telecommunication | 64 | |
| Kinneret Savitsky | Compugen | 50 | |
| Joshua Rosensweig | Bezeq Israeli Telecommunication | 63 | |
| Ami Barlev | Bezeq Israeli Telecommunication | 39 | |
| David Granot | Bezeq Israeli Telecommunication | 71 | |
| Shlomo Rodav | Bezeq Israeli Telecommunication | 67 | |
| Rami Nomkin | Bezeq Israeli Telecommunication | 68 | |
| Yair Aharonowitz | Compugen | 73 | |
| Doron Turgeman | Bezeq Israeli Telecommunication | 49 | |
| Amikam Shorer | Bezeq Israeli Telecommunication | 49 | |
| Tali Simon | Bezeq Israeli Telecommunication | 48 | |
| Michal Preminger | Compugen | N/A | |
| Ilan Biran | Bezeq Israeli Telecommunication | 70 | |
Management Performance
| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 |
BioLight Life Sciences Leadership Team
Elected by the shareholders, the BioLight Life's board of directors comprises two types of representatives: BioLight Life inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLight. The board's role is to monitor BioLight Life's management team and ensure that shareholders' interests are well served. BioLight Life's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLight Life's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Eliahu Shohet, Director | ||
| Tamar Kfir, External Director | ||
| Yifftach CPA, Chief Officer | ||
| Eliahu Hasidim, CFO | ||
| Tali Amar, Controller | ||
| Yifftach Biel, Finance Director | ||
| Ronit Gross, CoFounder | ||
| Efrat Makov, Director | ||
| Suzana NahumZilberberg, CEO | ||
| Rina Shafir, External Director | ||
| Jran Zhang, Director | ||
| Ron Mayron, Independent Director | ||
| Jacob Faigenbaum, Independent Director | ||
| Karin Gurevitz, Vice President General Counsel, Secretary | ||
| Israel Makov, Chairman of the Board | ||
| Ron MD, Chief Board | ||
| Yaacov Michlin, Chief Officer | ||
| Ronen Leibovitz, Internal Auditor |
BioLight Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioLight Life a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0911 | |||
| Return On Asset | -0.0925 | |||
| Current Valuation | 13.59 M | |||
| Shares Outstanding | 4.56 M | |||
| Shares Owned By Insiders | 56.36 % | |||
| Shares Owned By Institutions | 9.12 % | |||
| Price To Earning | 82.18 X | |||
| Price To Book | 0.61 X | |||
| Price To Sales | 4,937 X | |||
| Revenue | 3 K |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards BioLight Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, BioLight Life's short interest history, or implied volatility extrapolated from BioLight Life options trading.
Pair Trading with BioLight Life
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioLight Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioLight Life will appreciate offsetting losses from the drop in the long position's value.Moving against BioLight Stock
| 0.66 | HARL | Harel Insurance Inve | PairCorr |
| 0.65 | MGDL | Migdal Insurance | PairCorr |
| 0.52 | DSCT | Israel Discount Bank | PairCorr |
The ability to find closely correlated positions to BioLight Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioLight Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioLight Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioLight Life Sciences to buy it.
The correlation of BioLight Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioLight Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioLight Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioLight Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioLight Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Complementary Tools for BioLight Stock analysis
When running BioLight Life's price analysis, check to measure BioLight Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLight Life is operating at the current time. Most of BioLight Life's value examination focuses on studying past and present price action to predict the probability of BioLight Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLight Life's price. Additionally, you may evaluate how the addition of BioLight Life to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |